Thyroid antibodies and levothyroxine effects in subclinical hypothyroidism: A pooled analysis of two randomized controlled trials

BACKGROUND: Antithyroid antibodies increase the likelihood of developing overt hypothyroidism, but their clinical utility remains unclear. No large randomized controlled trial (RCT) has assessed whether older adults with subclinical hypothyroidism (SHypo) caused by autoimmune thyroid disease derive...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyko, Christina, Blum, Manuel R., Abolhassani, Nazanin, Stuber, Mirah J., Del Giovane, Cinzia, Feller, Martin, Moutzouri, Elisavet, Oberle, Jolanda, Jungo, Katharina T., Collet, Tinh‐Hai, den Elzen, Wendy P. J., Poortvliet, Rosalinde K. E., Du Puy, Robert S., Dekkers, Olaf M., Trompet, Stella, Jukema, J. Wouter, Aujesky, Drahomir, Quinn, Terry, Westendorp, Rudi, Kearney, Patricia M., Gussekloo, Jacobijn, Van Heemst, Diana, Mooijaart, Simon P., Bauer, Douglas C., Rodondi, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796496/
https://www.ncbi.nlm.nih.gov/pubmed/35894851
http://dx.doi.org/10.1111/joim.13544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796496/
https://www.ncbi.nlm.nih.gov/pubmed/35894851
http://dx.doi.org/10.1111/joim.13544

Ejemplares similares